Please use this identifier to cite or link to this item:
|Title in Portuguese:||Pentoxifylline neuroprotective effects are possibly related to its anti-inflammatory and TNF-Alpha inhibitory properties, in the 6-OHDA model of Parkinson’s disease|
|Author:||Neves, Kelly Rose Tavares|
Nobre Júnior, Hélio Vitoriano
Leal, Luzia Kalyne A. M.
Andrade, Geanne Matos de
Brito, Gerly Anne de Castro
Viana, Glauce Socorro de Barros
|Keywords:||Doença de Parkinson|
|Citation:||NEVES, K. R. T. et al. Pentoxifylline neuroprotective effects are possibly related to Its anti-Inflammatory and TNF-Alpha inhibitory properties, in the 6-OHDA model of Parkinson’s disease. Parkinson's Disease, v. 2015, p. 1-16, 2015.|
|Abstract:||Pentoxifylline (PTX) is a phosphodiesterase inhibitor with anti-TNF-alpha activity, associated with its anti-inflammatory action. Considering Parkinson’s disease (PD) as a neuroinflammatory disorder, the objectives were to evaluate PTX neuroprotective properties, in a model of PD. Male Wistar rats, divided into sham-operated (SO), untreated 6-OHDA, and 6-OHDA treated with PTX (10, 25, and 50 mg/kg) groups, received a unilateral 6-OHDA injection, except the SO group administered with saline. Treatments started 24 h after surgery and continued for 15 days when the animals were submitted to apomorphine-induced rotations, open field, and forced swimming tests. At the next day, they were euthanized and their striata processed for neurochemical (DA and DOPAC determinations), histological, and immunohistochemical (Fluoro-Jade, TH, DAT, OX-42, TNF-alpha, COX-2, and iNOS) studies. PTX reversed the behavioral changes observed in the untreated 6-OHDA animals. Furthermore, PTX partially reversed the decrease in DA contents and improved neuronal viability. In addition, decreases in immunostaining for TH and dopamine transporter (DAT) were reversed. The untreated 6-OHDA group showed intense OX-42, TNF-alpha, COX-2, and iNOS immunoreactivities, which were attenuated by PTX. In conclusion, we demonstrated a neuroprotective effect of PTX, possibly related to its anti-inflammatory and antioxidant actions, indicating its potential as an adjunct treatment for PD.|
|metadata.dc.type:||Artigo de Periódico|
|Appears in Collections:||PPGF - Artigos publicados em revistas científica|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.